These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22918773)

  • 1. Combined PET/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients.
    Thorwarth D; Müller AC; Pfannenberg C; Beyer T
    Recent Results Cancer Res; 2013; 194():425-39. PubMed ID: 22918773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
    Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.
    Gehler B; Paulsen F; Oksüz MO; Hauser TK; Eschmann SM; Bares R; Pfannenberg C; Bamberg M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2009 Nov; 4():56. PubMed ID: 19922642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of
    Stade F; Dittmar JO; Jäkel O; Kratochwil C; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2018 Apr; 13(1):58. PubMed ID: 29606149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
    Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
    Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 68Ga-DOTATOC PET/MRI on robotic radiosurgery treatment planning in meningioma patients: first experiences in a single institution.
    Acker G; Kluge A; Lukas M; Conti A; Pasemann D; Meinert F; Anh Nguyen PT; Jelgersma C; Loebel F; Budach V; Vajkoczy P; Furth C; Baur ADJ; Senger C
    Neurosurg Focus; 2019 Jun; 46(6):E9. PubMed ID: 31153151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
    Afshar-Oromieh A; Giesel FL; Linhart HG; Haberkorn U; Haufe S; Combs SE; Podlesek D; Eisenhut M; Kratochwil C
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1409-15. PubMed ID: 22669255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid PET/MRI of intracranial masses: initial experiences and comparison to PET/CT.
    Boss A; Bisdas S; Kolb A; Hofmann M; Ernemann U; Claussen CD; Pfannenberg C; Pichler BJ; Reimold M; Stegger L
    J Nucl Med; 2010 Aug; 51(8):1198-205. PubMed ID: 20660388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET.
    Combs SE; Welzel T; Habermehl D; Rieken S; Dittmar JO; Kessel K; Jäkel O; Haberkorn U; Debus J
    Acta Oncol; 2013 Apr; 52(3):514-20. PubMed ID: 23402336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series.
    Graf R; Plotkin M; Steffen IG; Wurm R; Wust P; Brenner W; Budach V; Badakhshi H
    Head Face Med; 2012 Jan; 8():1. PubMed ID: 22217329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
    Milker-Zabel S; Zabel-du Bois A; Henze M; Huber P; Schulz-Ertner D; Hoess A; Haberkorn U; Debus J
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):222-7. PubMed ID: 16488553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of
    Rodriguez J; Martinez G; Mahase S; Roytman M; Haghdel A; Kim S; Madera G; Magge R; Pan P; Ramakrishna R; Schwartz TH; Pannullo SC; Osborne JR; Lin E; Knisely JPS; Sanelli PC; Ivanidze J
    AJNR Am J Neuroradiol; 2023 Jul; 44(7):783-791. PubMed ID: 37290818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of 68Ga-DOTA-(Tyr3)-Octreotate PET/CT for Improved Target Definition in Radiotherapy Treatment Planning of Meningiomas - A Case Report.
    Grzbiela H; Tarnawski R; D'Amico A; Stąpór-Fudzińska M
    Curr Radiopharm; 2015; 8(1):45-8. PubMed ID: 25808961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.
    Ruf J; Heuck F; Schiefer J; Denecke T; Elgeti F; Pascher A; Pavel M; Stelter L; Kropf S; Wiedenmann B; Amthauer H
    Neuroendocrinology; 2010; 91(1):101-9. PubMed ID: 19996582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
    Afshar-Oromieh A; Wolf MB; Kratochwil C; Giesel FL; Combs SE; Dimitrakopoulou-Strauss A; Gnirs R; Roethke MC; Schlemmer HP; Haberkorn U
    Neuro Oncol; 2015 Feb; 17(2):312-9. PubMed ID: 25008094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning.
    Leibfarth S; Mönnich D; Welz S; Siegel C; Schwenzer N; Schmidt H; Zips D; Thorwarth D
    Acta Oncol; 2013 Oct; 52(7):1353-9. PubMed ID: 23879651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of [
    Milosevic A; Styczen H; Grueneisen J; Li Y; Weber M; Fendler WP; Kirchner J; Damman P; Wrede K; Lazaridis L; Glas M; Guberina M; Eckstein A; Blau T; Herrmann K; Umutlu L; Forsting M; Deuschl C; Schaarschmidt B
    J Nucl Med; 2023 Aug; 64(8):1185-1190. PubMed ID: 37385668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas.
    Dittmar JO; Kratochwil C; Dittmar A; Welzel T; Habermehl D; Rieken S; Giesel FL; Haberkorn U; Debus J; Combs SE
    Radiat Oncol; 2017 Nov; 12(1):169. PubMed ID: 29110720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.